# Oxygen-dependent modulation of the human complement system during acute normobaric hypoxia: a translational plasma proteomics study

**Authors:** Alexander Lang, Tin Yau Pang, Sarah Piel, Daniel Oehler, Elric Zweck, Khatereh Shahrjerdi, Madlen Okkasian, Jacqueline Georgy, Yvonne Reinders, Ashley-Jane Duplessis, Jens Tank, Jens Jordan, Susanne Pfeiler, Albert Sickmann, Malte Kelm, Christian Jung, Norbert Gerdes

PMC · DOI: 10.1007/s10238-026-02084-9 · Clinical and Experimental Medicine · 2026-02-21

## TL;DR

This study shows how oxygen levels affect complement proteins in blood during hypoxia and reoxygenation in healthy people.

## Contribution

The study reveals oxygen-dependent changes in complement proteins during hypoxia and reoxygenation using targeted plasma proteomics.

## Key findings

- Complement peptides like C1S, C3, and C9 decreased after reoxygenation compared to baseline and hypoxia.
- Hypoxia increased leukocyte and platelet counts but decreased hematocrit and mean corpuscular volume.
- Complement components showed coordinated changes during hypoxia and reoxygenation phases.

## Abstract

Acute hypoxia triggers multiple physiological and immune responses, yet the immediate systemic effects on circulating complement proteins remain insufficiently characterized. The complement cascade plays a central role in inflammation, host defense, and ischemia-related tissue injury, but its regulation during transient oxygen deprivation and reoxygenation in humans is poorly understood. Sixteen healthy volunteers were exposed to stepwise normobaric hypoxia simulating altitudes of 0, 2, 4, and 6 km (pO₂ = 9.64 kPa) followed by reoxygenation under normoxic conditions. Blood samples were collected at baseline, peak hypoxia (6 km), and after reoxygenation. Quantitative plasma proteomics was performed using targeted multiple-reaction-monitoring mass spectrometry to quantify key complement components (C1 complex, C3–C9, factor B) in 16 participants with complete datasets. Hematological parameters were analyzed in parallel. Hypoxia transiently increased leukocyte and platelet count, whereas hematocrit and mean corpuscular volume slightly decreased. While only slightly increasing during hypoxia, most complement peptides - including C1S, C1R, C3, C5, C7, C9, and CFAB - showed a coordinated reduction in relative abundance upon reoxygenation compared to both baseline and hypoxia (median fold-change ≈ 0.6–0.8; p < 0.05). Correlation analysis revealed coherent clustering among complement components but only weak associations with hematological indices. Acute hypoxia elicits rapid and reversible changes in the circulating complement peptide pool in healthy humans. Targeted plasma proteomics demonstrates clear oxygen-phase–dependent dynamics, with a coordinated decrease after reoxygenation. This pattern is consistent with reduced circulating availability of complement components, activation-associated consumption, and/or redistribution within the intravascular compartment. Future validation of these findings in certain patient cohorts may define translational relevance and functional consequences.

Sixteen healthy volunteers were exposed to stepwise normobaric hypoxia simulating altitudes of 0 km, 2 km, 4 km, and 6 km. Hypoxia increased plasma concentrations of several proteins of the complement system as analyzed by quantitative mass spectrometry. Upon reoxygenation, most complement peptides decreased to or below baseline.

## Linked entities

- **Proteins:** C1S (complement C1s), C1R (complement C1r), C3 (complement C3), C5 (complement C5), C7 (complement C7), C9 (complement C9), CFB (complement factor B)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** C1QB (complement C1q B chain) [NCBI Gene 713] {aka C1QD2}, C3 (complement C3) [NCBI Gene 718] {aka AHUS5, ARMD9, ASP, C3a, C3b, CPAMD1}, C9 (complement C9) [NCBI Gene 735] {aka ARMD15, C9D}, C1R (complement C1r) [NCBI Gene 715] {aka EDS8, EDSPD1}, C1QC (complement C1q C chain) [NCBI Gene 714] {aka C1Q-C, C1QD3, C1QG}, PMCH (pro-melanin concentrating hormone) [NCBI Gene 5367] {aka MCH, ppMCH}, C1RL (complement C1r subcomponent like) [NCBI Gene 51279] {aka C1RL1, C1RLP, C1r-LP, CLSPa}, CFH (complement factor H) [NCBI Gene 3075] {aka AHUS1, AMBP1, ARMD4, ARMS1, CFHL3, FH}, C7 (complement C7) [NCBI Gene 730], C5 (complement C5) [NCBI Gene 727] {aka C5D, C5a, C5b, CPAMD4, ECLZB}, CD55 (CD55 molecule (Cromer blood group)) [NCBI Gene 1604] {aka CHAPLE, CR, CROM, DAF, TC}, C5AR1 (complement C5a receptor 1) [NCBI Gene 728] {aka C5A, C5AR, C5R1, CD88}, CD59 (CD59 molecule (CD59 blood group)) [NCBI Gene 966] {aka 16.3A5, 1F5, EJ16, EJ30, EL32, G344}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, C1S (complement C1s) [NCBI Gene 716] {aka EDSPD2}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, CFB (complement factor B) [NCBI Gene 629] {aka AHUS4, ARMD14, BF, BFD, CFAB, CFBD}
- **Diseases:** inflammation (MESH:D007249), cardiogenic shock (MESH:D012770), tumor (MESH:D009369), ischemic (MESH:D002545), hypoxic (MESH:D002534), MODS (MESH:D009102), metabolic disorders (MESH:D008659), ischemia (MESH:D007511), Hypoxia (MESH:D000860), reperfusion (MESH:D015427), complement deficiency (MESH:D007153), cardiovascular disease (MESH:D002318), myocardial infarction (MESH:D009203), COVID-19 (MESH:D000086382), endothelial injury (MESH:D057772), heart failure (MESH:D006333), immune dysregulation (OMIM:614878), necrosis (MESH:D009336), ischemic tissue injury (MESH:D017695)
- **Chemicals:** FA (MESH:C030544), Oxygen (MESH:D010100), nitrogen (MESH:D009584), EDTA (MESH:D004492), acetonitrile (MESH:C032159), iodoacetamide (MESH:D007460), DTT (MESH:D004229), CRC1116 (-), TSQ (MESH:C061730), carbon dioxide (MESH:D002245), Creatinine (MESH:D003404), reactive oxygen species (MESH:D017382), pO2 (MESH:C093415)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932311/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932311/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932311/full.md

---
Source: https://tomesphere.com/paper/PMC12932311